What happened to those suffering adverse events in the Pfizer Phase 3 clinical trial and those in the post marketing authorization report?

Maybe a million Americans have died from the injections since the launch of the experimental injections and perhaps 40 million have had their immune systems permanently compromised.

There is a subset of those killed and injured that would reveal the extent of lethality and harms for which information should be easy enough to track, to at least inform a much needed analysis and debate of data.

I have often referred to the FAILED Pfizer Phase 3 clinical trial results here – (anyone know the end date for the Phase 4 reporting that will take the injection from emergency use to full approval?)

The COVID-19 Inoculations - More Harm Than Good FINAL Video & Print (canadiancovidcarealliance.org)

And this table from page 11: The clinical trial was supposed to run from 31 July 2020to 31 January 2021, but was unblinded months early – with the FDA granting emergency use authorization on 20 December 2020 – 7 weeks BEFORE the trial was due to end.

For these people:

Pfizer committed various acts of fraud – by commission (falsifying results – as per Brook Jackson testimony) and fraud by omission by not pointing out that the “infection and transmission#2 were NOY clinical end points, neither was hospitalisation or death. Only the reduction of severe symptoms (cytokine storms). Arguably, even if symptoms were reduced this would turn obvious symptomatic carriers into opaque asymptomatic carriers.

Look at those numbers. There is no indication of recoveries In either the treatment group of the placebo group. What is everyone were RT-PCR positive during the period of the clinical trial? Wouldn’t that invalidate the need to inject them?

Anyway, the question is “how did the trial participants fare AFTER the trial ended?” How many died, became hospitalized, recovered from infection in either group and so on.

As it is, those injected suffered more severe (life altering) and serious (life threatening) events. More people died as well (see page 12 for 20 deaths in the injected group v 14 in the placebo group).

The clinical trial had the advantage of being fully reported – no under reporting factor – just fraudulent results.

Now let’s turn to the post marketing authorisation report. Covering the 2 and a half month period ending on 29 February 2021.

From here page 7 of 38:

reissue_5.3.6-postmarketing-experience.pdf (phmpt.org)

The report was reissued to include the number of doses shipped – 126 million, although 70 million or so were actually injected – thus misrepresenting the relative lethality and harms.

Less than half the adverse events were “Recovered/Recovering”.

Staggeringly – with zero follow-up – 9,400 outcomes are “Unknown” and 11,367 “Not Recovered” – ALMOST HALF of reported adverse events.

Note that this reporting could very well be subject to an under reporting factor of around 40 or more – probably closer to 60. At the time of the roll-out, medics were still in panic mode and most had no idea what or where there adverse event reporting systems were, let alone had the 45 minutes to one hour needed to report the adverse events or death. Note that one in 9 deaths reported in VAERS occurred within 24 hours of injection (was the same true for those 1,223 deaths reported in the post marketing authorization reporting period?

So, you could multiply the 42,000 reports and 1,223 deaths by between 40 and 100 to get a better estimate of casualties and deaths. Maybe 1.6 million adverse events and more than 48,000 deaths?

Again, the question is how did the people with adverse event reports fare AFTER the trial ended?”

Why is this information not available?

Onwards!

Please buy a subscription or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan - an annual subscription of 100 bucks is one third less than a $3 coffee a week!